Pulmonx Corp Earnings Estimate

LUNG Stock  USD 8.68  0.24  2.69%   
By analyzing Pulmonx Corp's earnings estimates, investors can diagnose different trends across Pulmonx Corp's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Pulmonx Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Pulmonx Corp is projected to generate -0.383975 in earnings per share on the 31st of December 2025. Pulmonx Corp earnings estimates show analyst consensus about projected Pulmonx Corp EPS (Earning Per Share). It derives the highest and the lowest estimates based on Pulmonx Corp's historical volatility. Many public companies, such as Pulmonx Corp, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Pulmonx Corp's earnings estimates, investors can diagnose different trends across Pulmonx Corp's analyst sentiment over time as well as compare current estimates against different timeframes. The Pulmonx Corp's current Gross Profit is estimated to increase to about 61.3 M, while Pretax Profit Margin is projected to decrease to (1.06).
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Pulmonx Corp Earnings per Share Projection vs Actual

About Pulmonx Corp Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pulmonx Corp earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Pulmonx Corp estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Pulmonx Corp fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-370 M-351.5 M
Retained Earnings Total Equity-315.3 M-331.1 M
Earnings Yield(0.14)(0.15)
Price Earnings Ratio(7.16)(7.52)
Price Earnings To Growth Ratio(14.55)(13.82)

Currently Active Assets on Macroaxis

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.44)
Revenue Per Share
2.142
Quarterly Revenue Growth
0.233
Return On Assets
(0.21)
Return On Equity
(0.55)
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.